ATE446766T1 - Verwendung von alpha-s2 casein vorläufer- abgeleiteten peptiden - Google Patents

Verwendung von alpha-s2 casein vorläufer- abgeleiteten peptiden

Info

Publication number
ATE446766T1
ATE446766T1 AT03718925T AT03718925T ATE446766T1 AT E446766 T1 ATE446766 T1 AT E446766T1 AT 03718925 T AT03718925 T AT 03718925T AT 03718925 T AT03718925 T AT 03718925T AT E446766 T1 ATE446766 T1 AT E446766T1
Authority
AT
Austria
Prior art keywords
peptide
alpha
casein
casein precursor
derived peptides
Prior art date
Application number
AT03718925T
Other languages
English (en)
Inventor
John Arthur Smith
Original Assignee
Pepsyn Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepsyn Ltd filed Critical Pepsyn Ltd
Application granted granted Critical
Publication of ATE446766T1 publication Critical patent/ATE446766T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03718925T 2002-04-24 2003-04-02 Verwendung von alpha-s2 casein vorläufer- abgeleiteten peptiden ATE446766T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0209384.7A GB0209384D0 (en) 2002-04-24 2002-04-24 Peptide composition
PCT/GB2003/001439 WO2003091274A2 (en) 2002-04-24 2003-04-02 Use of alpha-s2 casein precursor-derived peptided

Publications (1)

Publication Number Publication Date
ATE446766T1 true ATE446766T1 (de) 2009-11-15

Family

ID=9935427

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03718925T ATE446766T1 (de) 2002-04-24 2003-04-02 Verwendung von alpha-s2 casein vorläufer- abgeleiteten peptiden

Country Status (8)

Country Link
US (2) US20060019884A1 (de)
EP (1) EP1501538B1 (de)
JP (1) JP2005531539A (de)
AT (1) ATE446766T1 (de)
AU (1) AU2003222959A1 (de)
DE (1) DE60329838D1 (de)
GB (1) GB0209384D0 (de)
WO (1) WO2003091274A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209384D0 (en) 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition
WO2010071132A1 (ja) 2008-12-15 2010-06-24 カルピス株式会社 皮膚老化抑制ペプチド

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
JPH03255095A (ja) 1990-03-02 1991-11-13 Kanebo Ltd カゼインペプチド
DE69127020T2 (de) 1990-05-18 1998-01-29 Iwase Cosfa Co Ltd Milchproteinhydrolysate und Zusammensetzungen zur Verwendung als Haar- und Hautbehandlungsmittel
AUPN271295A0 (en) 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
JP3962427B2 (ja) 1990-07-13 2007-08-22 グロペップ リミテッド 成長促進剤
FR2673374A1 (fr) 1991-03-01 1992-09-04 Oreal Composition cosmetique contenant comme ingredient actif un peptide a activite opiouide.
CH684773A5 (fr) * 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
JPH06211689A (ja) 1993-01-19 1994-08-02 Kanebo Ltd 鎮静剤及び精神安定用食品
US5965536A (en) * 1993-12-15 1999-10-12 Board Of Regents, The University Of Texas System Methods of inhibiting CXC intercrine molecules
AUPM534794A0 (en) 1994-04-28 1994-05-19 Gropep Pty Ltd Modified milk growth factor
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
GB9522302D0 (en) * 1995-10-31 1996-01-03 Univ Liverpool Growth promoters
AU732775B2 (en) 1997-05-19 2001-04-26 Colgate-Palmolive Company, The Fluoride free dental remineralization
JP3255095B2 (ja) 1997-09-30 2002-02-12 日本電気株式会社 研磨液および研磨方法
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
CA2296311A1 (en) * 1999-01-28 2000-07-28 Universite Laval Enzymatic hydrolysate of milk proteins
GB0016189D0 (en) * 2000-06-30 2000-08-23 Pepsyn Ltd Cosmetic composition
GB0209384D0 (en) 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition

Also Published As

Publication number Publication date
AU2003222959A1 (en) 2003-11-10
WO2003091274A3 (en) 2003-12-24
US7786081B2 (en) 2010-08-31
WO2003091274A2 (en) 2003-11-06
US20070160558A1 (en) 2007-07-12
EP1501538A2 (de) 2005-02-02
US20060019884A1 (en) 2006-01-26
AU2003222959A8 (en) 2003-11-10
DE60329838D1 (de) 2009-12-10
JP2005531539A (ja) 2005-10-20
EP1501538B1 (de) 2009-10-28
GB0209384D0 (en) 2002-06-05

Similar Documents

Publication Publication Date Title
ATE309358T1 (de) Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein
ATE334694T1 (de) Verwendung von thymulinähnlichen peptiden zur herstellung von schmerzmitteln
AU6410201A (en) Peptide composition
ATE257859T1 (de) Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit
ATE393631T1 (de) Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen
ATE5314T1 (de) Pharmakologisch aktive peptide und deren zusammensetzungen.
DK39591A (da) Peptidforbindelser
DE60329838D1 (de) Verwendung von alpha-s2 casein vorläufer-abgeleiteten peptiden
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
DE69837265D1 (de) Polypeptide zur regenerierung des nervensystems
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
ES2060134T3 (es) Inhibidor de tejido de metaloproteasas (timp-2).
NZ591825A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
ATE510008T1 (de) Entzündungshemmende peptide
GB9914480D0 (en) Use of peptides
IL163799A0 (en) Vegf peptides and their use
JP2005518355A5 (de)
ATE92078T1 (de) Pharmakologisch aktive peptide.
FI20050753A0 (fi) Uudet peptidit
DE60108739D1 (de) Herstellung von n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanin-1-methylester durch verwendung vom l-alpha-aspartyl-l-phenylalanin-1-methylester als vorläufer
WO2004048409A3 (en) Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
ATE452139T1 (de) Peptid-köder zur herstellung von medikamenten, die für die prävention oder behandlung von autoimmunerkrankungen bzw. problemen, die mit dem auftreten von gegen exogene proteine gerichteten antikörpern in zusammenhang stehen, bestimmt sind
ATE46173T1 (de) Pharmakologisch aktive peptide.
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties